搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Salmonella choleraesuis Protein RnfH (rnfH) CSB-YP710281SBF
CSB-EP710281SBF
CSB-BP710281SBF
CSB-MP710281SBF
CSB-EP710281SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Cysteine/O-acetylserine efflux protein (eamB), partial CSB-YP710282SBF1
CSB-EP710282SBF1
CSB-BP710282SBF1
CSB-MP710282SBF1
CSB-EP710282SBF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Pyridoxine 5'-phosphate synthase (pdxJ) CSB-YP710283SBF
CSB-EP710283SBF
CSB-BP710283SBF
CSB-MP710283SBF
CSB-EP710283SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis tRNA (cytidine/uridine-2'-O-)-methyltransferase TrmJ (trmJ) CSB-YP710284SBF
CSB-EP710284SBF
CSB-BP710284SBF
CSB-MP710284SBF
CSB-EP710284SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Nucleoside diphosphate kinase (ndk) CSB-YP710285SBF
CSB-EP710285SBF
CSB-BP710285SBF
CSB-MP710285SBF
CSB-EP710285SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis GMP synthase [glutamine-hydrolyzing] (guaA), partial CSB-YP710286SBF
CSB-EP710286SBF
CSB-BP710286SBF
CSB-MP710286SBF
CSB-EP710286SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Acetyltransferase YpeA (ypeA) CSB-YP710287SBF
CSB-EP710287SBF
CSB-BP710287SBF
CSB-MP710287SBF
CSB-EP710287SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis DNA ligase (ligA), partial CSB-YP710288SBF
CSB-EP710288SBF
CSB-BP710288SBF
CSB-MP710288SBF
CSB-EP710288SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis UPF0208 membrane protein YfbV (yfbV), partial CSB-YP710289SBF1
CSB-EP710289SBF1
CSB-BP710289SBF1
CSB-MP710289SBF1
CSB-EP710289SBF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis NADH-quinone oxidoreductase subunit H (nuoH), partial CSB-YP710290SBF
CSB-EP710290SBF
CSB-BP710290SBF
CSB-MP710290SBF
CSB-EP710290SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase (menD), partial CSB-YP710291SBF
CSB-EP710291SBF
CSB-BP710291SBF
CSB-MP710291SBF
CSB-EP710291SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis 2-keto-3-deoxy-L-rhamnonate aldolase (rhmA) CSB-YP710292SBF
CSB-EP710292SBF
CSB-BP710292SBF
CSB-MP710292SBF
CSB-EP710292SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Cytochrome c biogenesis ATP-binding export protein CcmA 1 (ccmA1) CSB-YP710293SBF
CSB-EP710293SBF
CSB-BP710293SBF
CSB-MP710293SBF
CSB-EP710293SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Probable endonuclease 4 (nfo) CSB-YP710294SBF
CSB-EP710294SBF
CSB-BP710294SBF
CSB-MP710294SBF
CSB-EP710294SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Probable lipid kinase YegS (yegS) CSB-YP710295SBF
CSB-EP710295SBF
CSB-BP710295SBF
CSB-MP710295SBF
CSB-EP710295SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Uridine kinase (udk) CSB-YP710296SBF
CSB-EP710296SBF
CSB-BP710296SBF
CSB-MP710296SBF
CSB-EP710296SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis UPF0265 protein yeeX (yeeX) CSB-YP710297SBF
CSB-EP710297SBF
CSB-BP710297SBF
CSB-MP710297SBF
CSB-EP710297SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Cobyric acid synthase (cobQ), partial CSB-YP710298SBF
CSB-EP710298SBF
CSB-BP710298SBF
CSB-MP710298SBF
CSB-EP710298SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Flagellar hook-basal body complex protein FliE (fliE) CSB-YP710299SBF
CSB-EP710299SBF
CSB-BP710299SBF
CSB-MP710299SBF
CSB-EP710299SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Arginine--tRNA ligase (argS), partial CSB-YP710300SBF
CSB-EP710300SBF
CSB-BP710300SBF
CSB-MP710300SBF
CSB-EP710300SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>